Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.
Nagano K, et al.
Biochem Biophys Res Commun. 2014 Jul 18;450(1):545-9. doi: 10.1016/j.bbrc.2014.06.007. Epub 2014 Jun 9.
Biochem Biophys Res Commun. 2014.
PMID: 24924629